Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,991 | -36,412 | -43,883 | -21,426 | -16,516 |
| Depreciation Amortization | 6,579 | 8,680 | 3,278 | 3,281 | 2,909 |
| Income taxes - deferred | -4,516 | -7,376 | -3,281 | 0 | N/A |
| Accounts receivable | -80 | -63 | 379 | -381 | 141 |
| Other Working Capital | 3,305 | -827 | 2,731 | 258 | 28 |
| Other Operating Activity | -2,841 | -2,856 | 11,267 | -1,412 | -157 |
| Operating Cash Flow | $-44,544 | $-38,854 | $-29,509 | $-19,680 | $-13,594 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,334 | -693 | -2,246 | -396 | -960 |
| Net Acquisitions | N/A | N/A | N/A | 292 | -241 |
| Purchase Of Investment | -1,248 | 0 | 0 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -2 |
| Other Investing Activity | -859 | -315 | -1,419 | -1 | -2 |
| Investing Cash Flow | $-7,441 | $-1,008 | $-3,665 | $-105 | $-1,203 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 255 | 471 | 0 | 0 | N/A |
| Debt Repayment | -59 | -26 | 0 | 0 | N/A |
| Common Stock Issued | 61,483 | 60,001 | 35,082 | 1,951 | 3,862 |
| Other Financing Activity | 3,096 | 3,177 | -818 | -37 | 0 |
| Financing Cash Flow | $64,775 | $63,623 | $34,264 | $1,913 | $3,862 |
| Exchange Rate Effect | -48 | 230 | 56 | 9 | -179 |
| Beginning Cash Position | 29,487 | 5,496 | 4,350 | 22,212 | 33,325 |
| End Cash Position | 42,229 | 29,487 | 5,496 | 4,350 | 22,212 |
| Net Cash Flow | $12,742 | $23,991 | $1,146 | $-17,862 | $-11,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,544 | -38,854 | -29,509 | -19,680 | -13,594 |
| Capital Expenditure | -5,334 | -702 | -2,277 | -401 | -960 |
| Free Cash Flow | -49,878 | -39,556 | -31,786 | -20,080 | -14,554 |